Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study

Brain and Development

Volumn 17, Issue SUPPL. 1, 1995, Pages 39-43

  Reitter, Bernd ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Deflazacort; Duchenne muscular dystrophy; Prednisone

Indexed keywords

ALKALINE PHOSPHATASE; CORTICOSTEROID; CREATINE KINASE; DEFLAZACORT; OSTEOCALCIN; PREDNISONE;

ALKALINE PHOSPHATASE BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MULTICENTER STUDY; MUSCLE STRENGTH; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; WEIGHT GAIN;

ALKALINE PHOSPHATASE; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MALE; MUSCLE CONTRACTION; MUSCULAR DYSTROPHIES; NEUROLOGY; PREDNISONE; PREGNENEDIONES;

EID: 0029555074     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/0387-7604(95)00015-1     Document Type: Article

References (24)

1. Prednisone in Duchenne muscular dystrophy
2. Failure of corticosteroid in the treatment Duchenne (pseudohypertrophic) muscular dystrophy. Report of a clinically matched three year double blind study
3. Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone
4. Prednisone therapy in Duchenne muscular dystrophy. Long term benefit
5. Randomized double blind six month trial of prednisone in Duchenne muscular dystrophy
6. Prednisone treatment of Duchenne dystrophy
7. Prednisone in Duchenne dystrophy. A randomized controlled trial defining the time course and dose response
8. A comparison of daily and alternate day prednisone therapy in the treatment of Duchenne muscular dystrophy
9. Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls
10. Corticocosteroid therapy in Duchenne muscular dystrophy
11. Mononuclear cell analysis of muscle biopsies in prednisone treated and untreated Duchenne muscular dystrophy
12. Histochemical and ultrastructural changes in rat muscle: occurrence following adrenal corticotrophic hormone, glucocorticoids and starvation
13. Decreased break-down of muscle protein after prednisone therapy in Duchenne dystrophy
14. Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy
15. Comparison of subacute effects of oxazacort (deflazacort) and prednisone on mineral metabolism in man
16. Effects of prednisone and deflazacort on vertebrate bone mass
17. Glucose intolerance after short-term administration of corticosteroids in healthy subjects
18. Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis
19. Effects of long-term maintenance therapy with a new glucocorticoid deflazacort on mineral metabolism and statural growth
20. Immunosuppressive effects of deflazacort, a new glucocorticoid with bone-sparing and carbohydrate-sparing properties: comparison with prednisone
21. A trial with a new steroid in Duchenne muscular dystrophy
22. Steroids in Duchenne muscular dystrophy deflazacort trial
23. Deflazacort in Duchenne dystrophy: study of long-term effect
24. The utility of the MMT and myometry in DMD